Announcement on Convening the Q3 2025 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Beijing Konruns Pharmaceutical Co., Ltd. on 6ix
Earlier from Beijing Konruns Pharmaceutical
- Announcement on Result of Shareholding Reduction by Shareholder
- Report for Q3 2025
- Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Not Subject to Sales Restrictions Concerning Share Repurchase
- Announcement on Repurchasing Shares through Call Auction for the 1st Time and Progress in Share Repurchase
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
Later from Beijing Konruns Pharmaceutical
- Announcement on Implementing Repurchase and Cancellation under 2023 Restricted Stock Incentive Plan
- Announcement on Resolutions of the 18th Meeting of the 4th Board of Supervisors
- Announcement on Company Re-certified as High-tech Enterprise
- Announcement on FDA Approval for Clinical Trials of KC1086 Project
- Announcement on Election of Employee Director
Follow Beijing Konruns Pharmaceutical into a list and get an email when it puts out news.
Follow Beijing Konruns Pharmaceutical